Canaccord Genuity Group upgraded shares of Healwell AI (TSE:AID – Free Report) to a moderate buy rating in a research note published on Tuesday morning,Zacks.com reports.
Separately, TD Securities raised shares of Healwell AI to a “strong-buy” rating in a research report on Thursday, April 2nd. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Strong Buy”.
Check Out Our Latest Stock Analysis on AID
Healwell AI Stock Performance
Recommended Stories
- Five stocks we like better than Healwell AI
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Healwell AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healwell AI and related companies with MarketBeat.com's FREE daily email newsletter.
